Text Size

Fascia Iliaca Compartment Blockade as Analgesia for Hip Fractures in the Acute Phase

This study has been completed.
Sponsor:
Collaborator:
IMK Fonden
Information provided by:
Hvidovre University Hospital
ClinicalTrials.gov Identifier:
NCT00162630
First received: September 8, 2005
Last updated: September 13, 2006
Last verified: September 2006
History of Changes
  Purpose

To evaluate the analgesic potential of an neural blockade (Fascia iliaca compartment) with local anaesthetics in patients with hip fracture immediately after arrival in the emergency department.


Condition Intervention Phase
Hip Fracture
 Procedure: Fascia Iliaca Compartment Blockade
 Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Double-Blind
Primary Purpose: Treatment
Official Title: Fascia Iliaca Compartment Blockade as Analgesia for Hip Fractures in the Acute Phase

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Hvidovre University Hospital:

Primary Outcome Measures:
  • Pain relief within 3 hours

Secondary Outcome Measures:
  • Nausea
  • Pain on transfer
  • Discomfort with block placement

Estimated Enrollment: 48
Study Start Date: May 2003
Estimated Study Completion Date: March 2006
Detailed Description:

Hip fracture patients have severe pain in the acute phase. Traditional analgesic treatment have consisted of intramuscular morphine with its associated side effects. The trial evaluates the Fascia iliaca compartment compared to regular opioid pain therapy in hip fracture patinets immediately after arrival at the emergency department.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Primary hip fracture suspected
  • able to give informed consent
  • no substance abuse
  • no regular opioid therapy
  • no opioid treatment within the last 6 hours
  • morphine intolerance
  • allergies to local anaesthetics

Exclusion Criteria:

  • Fracture ruled out on x-ray
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00162630

Locations
Denmark
Hvidovre University Hospital
Hvidovre, Denmark, 2650
Sponsors and Collaborators
Hvidovre University Hospital
IMK Fonden
Investigators
Study Director: Nicolai B Foss, MD Hvidovre University Hospital
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00162630     History of Changes
Other Study ID Numbers: HHSG-rct-04
Study First Received: September 8, 2005
Last Updated: September 13, 2006
Health Authority: Denmark: National Board of Health

Keywords provided by Hvidovre University Hospital:
Hip fracture, pain, regional anaesthesia, analgesia

Additional relevant MeSH terms:
Fractures, Bone
Hip Fractures
Wounds and Injuries
 Femoral Fractures
Hip Injuries
Leg Injuries

ClinicalTrials.gov processed this record on May 19, 2013